A Study to Investigate the Effect of AZD5004 on Rosuvastatin, Atorvastatin, Simvastatin, Repaglinide and the Effect of Erythromycin on AZD5004 in Healthy Participants

NCT06948747 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

49

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Participants

Interventions

DRUG: AZD5004
DRUG: Rosuvastatin
DRUG: Erythromycin
DRUG: Atorvastatin
DRUG: Simvastatin
DRUG: Repaglinide

Sponsor

AstraZeneca